Trump signs order to ensure 'resilient' supply chain for essential medicines in US
ReutersAug 13, 2025 9:47 PM
Aug 13 (Reuters) - U.S. President Donald Trump signed an executive order aimed at ensuring a "resilient" supply chain for essential medicines in the U.S. by filling the Strategic Active Pharmaceutical Ingredients Reserve with critical drug components, the White House said on Wednesday.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
What Are On-Chain Perpetual Contracts? Why Are HYPE and ASTER Surging?
The explosive rise of HYPE and ASTER is more than just a price story — it’s a triumph of on-chain derivatives tech, token economics, and community-driven growth. As users demand greater transparency, security, and decentralization, on-chain perpetual contracts are poised to challenge and even replacTradingKey
3 hours ago
Investing in Advanced Chips & Foundry Stocks
All waves of technological development have a foundation, and today’s digital economy is grounded in the semiconductor industry. From smartphones and artificial intelligence to data centers and electric vehiclesTradingKey
4 hours ago
NVIDIA–Oracle–OpenAI: AI Growth Engine or Warning Signs of a Bubble?
TradingKey - Earlier this week, NVIDIA announced a preliminary partnership with OpenAI to jointly deploy 10 gigawatts of compute capacity.TradingKey
16 hours ago
Bitcoin Price Forecast: Trends and Investment Outlook from 2025 to 2030
From $0.01 in 2009 to $120,000+ in 2025, Bitcoin has evolved from obscurity to a globally recognized financial asset. While institutions and governments increasingly embrace it, investors must remain vigilant against volatility, security risks, and scams.TradingKey
Wed, Jul 16
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.TradingKey
Mon, Jul 14
Tradingkey
